8
Oct. 1-2, 2018 Omaha, Nebraska

Oct. 1-2, 2018 · 2018-09-19 · Histone Deacetylase Inhibitors (Colorado State – Cetya Therapeutics, Cliff Hendrick) 2 p.m. Technology Presentations Chemical Agents for Antifungal

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Oct. 1-2, 2018 · 2018-09-19 · Histone Deacetylase Inhibitors (Colorado State – Cetya Therapeutics, Cliff Hendrick) 2 p.m. Technology Presentations Chemical Agents for Antifungal

Oct. 1-2, 2018Omaha, Nebraska

Page 2: Oct. 1-2, 2018 · 2018-09-19 · Histone Deacetylase Inhibitors (Colorado State – Cetya Therapeutics, Cliff Hendrick) 2 p.m. Technology Presentations Chemical Agents for Antifungal

Pipeline to Product

Marshall, Gerstein & Borun LLP233 South Wacker Drive

6300 Willis Tower Chicago, IL 60606-6357 USA

marshallip.com

Protecting, enforcing, and transferring IP rights for the world’s leading innovators.

Page 4: Oct. 1-2, 2018 · 2018-09-19 · Histone Deacetylase Inhibitors (Colorado State – Cetya Therapeutics, Cliff Hendrick) 2 p.m. Technology Presentations Chemical Agents for Antifungal

www.mwdrugdevelopment.comOctober 1-2, 2018Omaha Marriott Downtown at the Capital District222 North 10th StreetOmaha, Nebraska

Day One Monday, October 18 a.m.

CONFERENCE SCHEDULE

Breakfast Check-in, complimentary breakfast, networking, partnering

8:45 a.m. Welcome Welcome, opening remarks, additional information

9 a.m. Technology Presentations Peptoid cancer drugs targeting PCNA (Purdue, Dr. V Jo Davisson) NF-kB Inhibitors (UNMC, Dr. Amar Natarajan) Prostate Cancer Vaccine (Iowa – Ohana Vaccines, Dr. David Lubaroff) Targeting Sigma-2 Receptor for Cancer (Wash U-Accuronix, Dr. William Hawkins)

10 a.m. Technology Presentations Broad Spectrum Antivirals (Missouri, Brian Buntaine) Novel Anthelmintic Drugs (Iowa St, Dr. Jack Hartwigsen) Immune Stimulating Peptides (UNMC – Prommune, Dr. Sam Al-Murrani) Super-antibiotic (Wash U – Viosera, Dr. Nicholas Goldner)

11 a.m. Technology Presentations Compounds for the Prevention of Heart Failure (Wash U – iCordis, Dr. Luigi Adamo) Peptides for Treatment of Ischemia/Reperfusion (Kansas State, Dr. Caronda Moore)

Noon Lunch Complimentary lunch, networking, partnering

1 p.m. Technology Presentations Carrier-free Nanoparticle Formulation (Purdue, Dr. Yoon Yeo) Her2 Targeted Antibody Drug Conjugate (Kansas, Dr. Blake Peterson) Theranostics for Personalized Medicine (Iowa – Viewpoint Molecular Targeting, Dr. Michael Schultz) Mps1 Kinase Inhibitors (Ohio State, Dr. Jerry Hilinski)

2 p.m. Technology Presentations Water Soluble Glucagon Derivative (Purdue, Dr. Joe Trebley) Soluble Antigen Arrays for Autoimmune Diseases (Kansas – Orion BioScience, Dr. Joshua Sestak) Therapy for the Reversal of Type 1 Diabetes (Missouri, Brian Buntaine) Fatty Acid Uptake Inhibitors (UNL, Dr. Concetta DiRusso)

3 p.m. Technology Presentations Long Acting Antiretroviral Formulations (UNMC, Dr. JoEllyn McMillan) Doped Nanoparticles as Antibacterial Agents (Oklahoma, Dr. Meredith Wilkerson) Delivery Platform for drugs and gene therapy (UNL, Dr. Srivatsan Kidambi) Natural Surfactant Helps With ARDS (Purdue – Spirrow Therapeutics, Davis Arick)

4 p.m. Cocktails Complimentary cocktails, networking, partnering

Page 5: Oct. 1-2, 2018 · 2018-09-19 · Histone Deacetylase Inhibitors (Colorado State – Cetya Therapeutics, Cliff Hendrick) 2 p.m. Technology Presentations Chemical Agents for Antifungal

www.mwdrugdevelopment.comOctober 1-2, 2018Omaha Marriott Downtown at the Capital District222 North 10th StreetOmaha, Nebraska

www.mwdrugdevelopment.comOctober 1-2, 2018Omaha Marriott Downtown at the Capital District222 North 10th StreetOmaha, Nebraska

Day One Monday, October 1

CONFERENCE SCHEDULE

Carrier-free Nanoparticle Formulation (Purdue, Dr. Yoon Yeo) Her2 Targeted Antibody Drug Conjugate (Kansas, Dr. Blake Peterson) Theranostics for Personalized Medicine (Iowa – Viewpoint Molecular Targeting, Dr. Michael Schultz) Mps1 Kinase Inhibitors (Ohio State, Dr. Jerry Hilinski)

Water Soluble Glucagon Derivative (Purdue, Dr. Joe Trebley) Soluble Antigen Arrays for Autoimmune Diseases (Kansas – Orion BioScience, Dr. Joshua Sestak) Therapy for the Reversal of Type 1 Diabetes (Missouri, Brian Buntaine) Fatty Acid Uptake Inhibitors (UNL, Dr. Concetta DiRusso)

Long Acting Antiretroviral Formulations (UNMC, Dr. JoEllyn McMillan) Doped Nanoparticles as Antibacterial Agents (Oklahoma, Dr. Meredith Wilkerson) Delivery Platform for drugs and gene therapy (UNL, Dr. Srivatsan Kidambi) Natural Surfactant Helps With ARDS (Purdue – Spirrow Therapeutics, Davis Arick)

Day Two Tuesday, October 28 a.m. Breakfast

Check-in, complimentary breakfast, networking, partnering

8:45 a.m. Welcome Welcome, opening remarks, additional information

9 a.m. Technology Presentations Hsp90 Selective Inhibitors (Kansas, Dr. Aswini Betha) Drug Delivery System for Targeting Multiple Myeloma (Wash U, Dr. Kareem Azab) CCL21 Nanoparticles for Cancer Immunotherapy (UNMC, Dr. Joyce Solheim) Selective Estrogen Receptor Modulator (Ohio State, Dr. Jerry Hilinski)

10 a.m. Technology Presentations Neuroprotection by Mitochondria-targeted Metformin (Iowa State, Dr. Jack Hartwigsen) Sensory Neuron Actin Remodeling in Pain (UNL-Neurocarrus, Dr. Paul Blum) SMN2 Catalytic Core for Spinal Muscle Atrophy (Iowa State, Dr. Jack Hartwigsen) Non-opioid for Treating Chronic Pain (Purdue, Dr. Daniel Flaherty)

11 a.m. Technology Presentations Gastric pH Control for the Treatment of Acid Reflux (Missouri, Brian Buntaine) Non-Invasive Leads for Eye Vascular Disease (Oklahoma, Dr. Meredith Wilkerson) Saracatinib for epileptic seizures (Iowa State, Dr. Jack Hartwigsen)

Noon Lunch Complimentary lunch, networking, partnering

1 p.m. Technology Presentations POSH Inhibitor-based Cancer Therapy (Missouri, Brian Buntaine) Anti-cancer Drugs Based on Natural Compounds (Iowa – InnoBioPharma, Dr. Zhendong Jin) TR3 Biologics for the Treatment of Cancer (Wash U, Dr. Dirk Spitzer) Histone Deacetylase Inhibitors (Colorado State – Cetya Therapeutics, Cliff Hendrick)

2 p.m. Technology Presentations Chemical Agents for Antifungal Applications (Kansas State, Dr. Govind Vediyappan) PHX Broad Spectrum Antiviral (Kansas – KanPro Research, Dr. Philip Gao) Copper-Activated Antibacterial Drugs (Kansas State, Dr. Stefan Bossmann) Influenza Vaccine (South Dakota, Dr. Rozzy Finn)

3 p.m. Wrap Up Partnering, networking, closing remarks

Page 6: Oct. 1-2, 2018 · 2018-09-19 · Histone Deacetylase Inhibitors (Colorado State – Cetya Therapeutics, Cliff Hendrick) 2 p.m. Technology Presentations Chemical Agents for Antifungal

Additional grant and funding support was

made possible by BBC Entreprenurial

Training & Consulting. Essential suport was also provide by the

University of Nebraska Medical Center and

its technology transfer and commercialization

office, UNeMed.

Scheduling one-on-one parterning meetingsAccess your meeting schedule, and schedule meetings via Meeting Mojo: http://mwdrugdevelopment.meeting-mojo.com/

Table listings for universities and sponsors � University of Iowa – 1 � Iowa State University – 2 � University of Kansas – 3 � Kansas State University – 4 � University of Missouri – 5 � University of Nebraska Lincoln – 6 � University of Nebraska Medical Center – 7 � Ohio State University – 8 � University of Oklahoma –9 � Purdue University – 10 � Washington University – 11 � Colorado State University – 12 � University of South Dakota – 13 � Marshall Gerstein & Borun LLP – 14 � Dann Dorfman Herrell & Skillman – 15 � Suiter Swantz IP – 16

All partnering meetings with a University representative (including start-ups) should initially meet at the Univer-sity’s table in the Network-ing Room (Capital 2).

If the university table is open, feel free to meet at that table. If it is in use, please locate an open table in the dining room (Capi-tal 1) or the tables in the pre-function space outside of the Capital 3 & 4 rooms.

Page 7: Oct. 1-2, 2018 · 2018-09-19 · Histone Deacetylase Inhibitors (Colorado State – Cetya Therapeutics, Cliff Hendrick) 2 p.m. Technology Presentations Chemical Agents for Antifungal

MORE THAN 40 YEARS PROVIDING TRUSTED LEGAL SERVICES

Dann Dorfman Herrell and Skillman specializes in the practice of Patent, Trademark, Copyright, and related Trade Secret and Unfair Competition Law. With many of our attorneys having advanced degrees, we have established a strong reputation for procuring strong IP rights that effectively protect our clients’ interests. Our experience in providing reliable and effective services to our clients for over forty years has sharpened our focus on the ultimate goal of IP protection - a successful enterprise.

HELPING MAKE OUR CLIENTS’ IDEAS A REALITYIntellectual property is a business tool. At Dann Dorfman Herrell and Skillman, we understand that our clients want business solutions, not merely legal solutions. We look beyond the day-to-day practice of patent, trademark, and copyright law and focus on how to best utilize the intellectual property to advance the business interests of our clients, whether they are a startup company, an academic institution, or a global corporate leader. Our attorneys recognize that technical innovations, product logos, or original works of authorship are of little value unless they afford their owners a competitive advantage in the marketplace. When the legal protection for these innovations is developed with a well-conceived business strategy in mind, remarkable commercial growth opportunities often follow.

Committed to bringing innovation from the theoretical to the practical, from the conceptual to the marketable.

Discover why Dann Dorfman Herrell and Skillman should help you put your intellectual property to work.

215-563-4100 www.ddhs.com

Page 8: Oct. 1-2, 2018 · 2018-09-19 · Histone Deacetylase Inhibitors (Colorado State – Cetya Therapeutics, Cliff Hendrick) 2 p.m. Technology Presentations Chemical Agents for Antifungal

The University of Nebraska does not discriminate based on race, color, ethnicity, national origin, sex, pregnancy, sexual orientation, gender identity, religion, disability, age, genetic information, veteran status, marital status, and/or political affiliation in its programs, activities, or employment.

www.mwdrugdevelopment.com

October 1-2, 2018

Omaha Marriott Downtown at the Capital District222 North 10th Street

Omaha, Nebraska